Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients

Authors

Lin Dong
Liang Wu (ORCID: https://orcid.org/0000-0002-8377-5834)
Wei Huang (ORCID: https://orcid.org/0000-0002-8894-0982)
Pei Wang (ORCID: https://orcid.org/0000-0003-3132-1336)
Kainan Xiong (ORCID: https://orcid.org/0000-0003-4508-6920)
Xiaolong Li (ORCID: https://orcid.org/0000-0003-1262-346X)
Yang Fu (ORCID: https://orcid.org/0009-0007-2995-2303)
Xiaolan Wang (ORCID: https://orcid.org/0000-0002-5589-7244)
Xi Chen (ORCID: https://orcid.org/0000-0002-8326-6271)
Jiang Fan (ORCID: https://orcid.org/0000-0001-6206-5414)
Yiran Cai (ORCID: https://orcid.org/0000-0002-5851-013X)

Institutions

Shanghai Jiao Tong University (CN)
Peking University (CN)
Peking University First Hospital (CN)
Shanghai First People's Hospital (CN)
Yangpu Hospital of Tongji University (CN)

Publication Details

Journal: Frontiers in Oncology
Published: 2025-07-24
DOI: https://doi.org/10.3389/fonc.2025.1563315
Primary Topic: Cancer Genomics and Diagnostics
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Natural Science Foundation of China
National Key Research and Development Program of China

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients

Lin Dong, Liang Wu, Wei Huang, Pei Wang et al.

Jul 24, 2025

Frontiers in Oncology

Cancer Genomics and Diagnostics

article

Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients

Lin Dong, Liang Wu, Wei Huang, Pei Wang, Kainan Xiong, Xiaolong Li, Yang Fu, Xiaolan Wang, Xi Chen, Jiang Fan, Yiran Cai

July 24, 2025article en

Abstract

No abstract available for this paper.

Frontiers in OncologyVol. 15

Shanghai Jiao Tong University (CN), Peking University (CN), Peking University First Hospital (CN), Shanghai First People's Hospital (CN), Yangpu Hospital of Tongji University (CN)

National Natural Science Foundation of China, National Key Research and Development Program of China

Good health and well-being

Openalex Percentile: Top 76%

Cancer Genomics and Diagnostics

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients — Lin Dong, Liang Wu, et al. · Frontiers in Oncology (2025) | TGRS Research Map | TGRS